6 Indian hospitals join PRIME programme to strengthen IV therapy

The programme includes structured goal setting, progress reviews, and webinars.

Six hospitals in India have joined the Preventing Risks of Infections and Medication Errors (PRIME) programme, launched by Becton, Dickinson and Company in partnership with Joint Commission International, which focuses on safer intravenous therapy practices.

The newly enrolled hospitals include Apollo Hospital, Greams Road (Chennai), BLK-Max Super Speciality Hospital (Delhi), Amala Institute of Medical Sciences (Thrissur), Apollo Hospital, Jubilee Hills (Hyderabad), HCG Aastha Cancer Centre (Ahmedabad), and Apollo Hospital, Visakhapatnam.

The six-month programme includes structured goal setting, progress reviews, expert tele-consultations, and scientific webinars to improve infection control and reduce medication errors.

Hospitals completing the programme are awarded a certification acknowledging their adherence to the safety standards in the PRIME framework.

PRIME, first introduced in India in 2019, has since been implemented in 30 hospitals nationwide.